ReaCastroMDMPH

Research • Raritan, NJ

Director of Medical Affairs

Join to view full profile

Dr. Castro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Castro's full profile

Already have an account?

Office
1001 US RT 202
Raritan, NJ 08869
Phone+1 224-436-5213
Is this information wrong?

Education & Training

Northern Illinois UniversityMaster in Public Health, Health Services Administration, 2014 - 2016
University of the East College of MedicineClass of 2001
University if Santo TomasBS, Medical Technology, 1993 - 1997

Clinical Trials

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas Start of enrollment: 2015 Feb 17
Completed
Phase 2
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate Start of enrollment: 2015 Dec 01
Active, not recruiting
Phase 3
A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY) Start of enrollment: 2016 Mar 23
Completed
Phase 3
A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease Start of enrollment: 2016 May 18
Active, not recruiting
Phase 2
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer Start of enrollment: 2018 Oct 10
Active, not recruiting
Phase 2
Join now to see all

Other Languages

Tagalog